Medicare-certified home health agencies with clean compliance histories and diversified payor mixes typically sell for 3.5x–6x EBITDA. Here's exactly what drives value — and what destroys it — when selling your agency.
Find Home Health Agency Businesses For SaleHome health agencies are most commonly valued on a multiple of EBITDA, reflecting the cash-generating potential of an active Medicare/Medicaid-certified operation with an established patient census and referral network. Buyers place a significant premium on agencies with strong CMS star ratings, clean billing compliance histories, and payor mix diversification beyond a single government program. Because of the complexity introduced by the CHOW process, CMS reimbursement exposure, and labor market conditions, valuation multiples vary meaningfully based on regulatory standing, staff retention risk, and the transferability of referral relationships.
3.5×
Low EBITDA Multiple
4.75×
Mid EBITDA Multiple
6×
High EBITDA Multiple
Home health agencies generating $1M–$5M in revenue typically trade at 3.5x–6x EBITDA. Agencies at the lower end of the range often carry compliance red flags such as open RAC audits, CMS survey deficiencies, or heavy owner dependency in clinical and administrative roles. Mid-range multiples of 4x–5x are common for well-run agencies with stable Medicare census, documented SOPs, and at least two years of clean financials. Premium multiples above 5x are reserved for agencies with 4–5 CMS star ratings, diversified payor mix including managed care and private pay, a capable non-owner management team, and strong referral source documentation — particularly those located in high-demand geographies targeted by PE-backed roll-up platforms.
$2,800,000
Revenue
$448,000
EBITDA
4.75x
Multiple
$2,128,000
Price
Asset purchase at $2,128,000 structured with 80% paid at close ($1,702,400) financed through an SBA 7(a) loan, a 10% seller note ($212,800) held for 24 months tied to CHOW approval and successful Medicare/Medicaid re-enrollment, and a 10% buyer equity injection ($212,800). A $150,000 holdback was escrowed for 12 months pending resolution of a minor CMS survey deficiency plan of correction and confirmation that the top three referral sources continued admitting patients at pre-close volumes.
EBITDA Multiple
The most widely used valuation method for home health agencies in the lower middle market. Buyers calculate trailing twelve-month EBITDA — adjusting for owner compensation, personal expenses run through the business, and any one-time items — then apply a market multiple based on agency quality, compliance profile, and strategic fit. For agencies generating $500K–$1.5M in adjusted EBITDA, multiples commonly range from 3.5x to 6x depending on payor mix, star ratings, and staff depth.
Best for: Agencies with at least 2–3 years of operating history, positive EBITDA margins of 10–20%, and verifiable Medicare/Medicaid reimbursement data that can be normalized for a buyer's underwriting process.
Revenue Multiple
Some buyers — particularly PE-backed roll-up platforms acquiring smaller tuck-in agencies — apply a revenue multiple when EBITDA is thin or the agency's value lies primarily in its Medicare certification, patient census, and geographic territory. Revenue multiples for home health agencies typically range from 0.5x–1.2x trailing revenue, adjusted for payor mix quality and census size. This method is most relevant for agencies with 50–100 active patients where the certification and referral network are the primary assets being acquired.
Best for: Smaller agencies with strong patient census and clean Medicare certification but compressed margins due to owner-operator labor costs or transitional expenses that a larger acquirer can eliminate post-close.
Discounted Cash Flow (DCF)
A DCF analysis projects future cash flows based on expected patient census growth, reimbursement rate assumptions under PDGM and HHVBP, and anticipated labor cost trends. Buyers use DCF to stress-test acquisition pricing against reimbursement headwinds and to model the impact of payor mix shifts. In home health M&A, DCF is typically used alongside EBITDA multiples as a sanity check rather than the primary valuation basis, given the regulatory uncertainty in CMS rate-setting.
Best for: Larger, more sophisticated acquisitions where buyers are modeling geographic expansion scenarios, managed care contract upside, or the financial impact of integrating the agency into an existing platform with shared overhead.
Strong CMS Star Ratings and Clinical Outcomes
Agencies with 4–5 star CMS ratings and measurable outcomes — including low 30-day hospitalization rates, high patient functional improvement scores, and strong OASIS documentation accuracy — command premium multiples. These ratings serve as third-party validation of clinical quality and are increasingly used by managed care plans and ACOs in selecting home health partners, making them a direct driver of future revenue diversification.
Diversified Payor Mix with Private Pay or Managed Care Contracts
Heavy concentration in traditional Medicare fee-for-service creates reimbursement risk as CMS continues to refine PDGM and expand HHVBP. Agencies with 20–40% of revenue from managed care, commercial insurance, or private pay clients are significantly more attractive to buyers because they demonstrate reduced government dependency and often carry higher per-episode margins. Documented managed care contracts with favorable rates are a tangible valuation premium.
Active Patient Census of 75–150+ Patients
A healthy, active census — typically 75 or more patients receiving skilled nursing or therapy services — demonstrates operational momentum and referral network strength. Buyers underwrite patient retention assumptions into their models, so agencies with long average lengths of service, low discharge-for-hospitalization rates, and consistent monthly admissions growth are viewed as lower-risk acquisitions with more predictable post-close revenue.
Institutional Referral Source Relationships
Agencies whose admissions flow from documented relationships with hospital discharge planners, physician groups, skilled nursing facilities, and ACOs — rather than solely from the owner's personal network — are significantly more transferable. Buyers will scrutinize whether referral relationships are institutional and documented or entirely dependent on the seller's relationships, which are at risk of attrition post-ownership transition.
Capable Non-Owner Clinical and Administrative Leadership
An agency where the owner is not the director of nursing, primary biller, and sole scheduler simultaneously commands a meaningful valuation premium. Buyers — especially PE-backed platforms — pay for operational infrastructure. Agencies with an employed DON, clinical supervisor, and billing coordinator who will remain post-close reduce transition risk and support a faster CHOW approval process with CMS.
Clean Compliance History and No Open CMS Investigations
A spotless compliance record — no outstanding RAC audit demands, no open CMS overpayment notices, no survey deficiency plans of correction, and a clean third-party billing audit — removes one of the largest risk discounts buyers apply in home health acquisitions. Agencies that proactively present a clean compliance portfolio with three years of audited billing data accelerate buyer confidence and support higher multiples.
Unresolved CMS Overpayment Demands or Open RAC Audits
Active Recovery Audit Contractor (RAC) audits, outstanding CMS overpayment demands, or unresolved billing compliance findings are among the most serious value destroyers in a home health transaction. Buyers will either demand a significant price reduction to escrow against potential liability, require the seller to resolve all findings before close, or walk away entirely. Agencies with known billing exposure should engage a healthcare compliance attorney and conduct an internal audit well before going to market.
Heavy Owner Dependency in Clinical and Administrative Roles
When the selling owner is also the director of nursing, the primary referral contact, and the day-to-day administrator, buyers face acute key-person risk. This scenario typically results in a lower multiple, a larger earnout tied to post-close patient census retention, or an extended seller employment agreement requirement. Building a management layer before exit is the single most impactful step an owner can take to protect valuation.
High Staff Turnover and Credentialing Gaps
A home health agency with chronic RN, LPN, or therapist turnover, unfilled skilled positions, or staff with lapsed credentials presents significant operational risk to buyers who must maintain clinical staffing ratios to stay in compliance and serve their census. High turnover is often a leading indicator of cultural or compensation issues that will follow the new owner — and buyers discount aggressively for it.
Revenue Concentration from a Single Referral Source
Agencies deriving 50% or more of admissions from a single hospital system, physician group, or ACO carry substantial concentration risk. If that referral relationship deteriorates post-close — due to the ownership transition, a change in hospital discharge policy, or a competitor relationship — the buyer faces immediate revenue exposure. Most sophisticated buyers cap acceptable single-source concentration at 25–30% of total admissions.
EVV Non-Compliance or Outdated Billing Systems
Electronic Visit Verification (EVV) is federally mandated for Medicaid-funded personal care and home health services. Agencies operating without a compliant EVV system, using paper-based documentation, or running outdated EHR platforms face both regulatory exposure and significant technology remediation costs post-close. Buyers factor these costs into their offer price or use them as a basis to renegotiate deal terms during due diligence.
Weak or Unaudited Financial Records
Agencies where personal and business expenses are commingled, where owner compensation is inconsistently reported, or where revenue is tracked at the cash basis without clean accrual-basis P&Ls present a major obstacle to buyer underwriting. SBA lenders and PE buyers alike require three years of clean tax returns and normalized financial statements. Sellers who cannot produce these documents face either a prolonged diligence process or a discounted offer reflecting the buyer's inability to accurately underwrite the business.
Find Home Health Agency Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most home health agencies in the $1M–$5M revenue range sell for 3.5x–6x adjusted EBITDA. The specific multiple you receive depends heavily on your CMS star rating, compliance history, payor mix diversification, patient census size, and whether your agency has clinical and administrative leadership in place that will survive the ownership transition. Agencies with clean Medicare certification, strong outcomes data, and institutional referral relationships consistently achieve multiples at or above 5x, while those with compliance exposure, thin management teams, or heavy Medicare fee-for-service dependency tend to land in the 3.5x–4.5x range.
The Change of Ownership (CHOW) process with CMS is one of the most significant transaction-specific risks in a home health acquisition. CHOW approval — required for the buyer to bill Medicare and Medicaid under the agency's existing certification — can take 90–180 days or longer, during which the agency typically continues operating under the seller's certification. Buyers manage this risk by structuring holdbacks or earnouts tied to successful CHOW completion and payor re-enrollment. Agencies with a clean CMS history, current accreditation, and no outstanding surveys move through CHOW faster, which directly supports deal certainty and can protect or enhance your sale price.
Yes — payor mix is one of the most scrutinized variables in home health agency valuation. Agencies with 70% or more of revenue from traditional Medicare fee-for-service are viewed as carrying higher reimbursement risk given ongoing PDGM adjustments and HHVBP expansion. Buyers — especially PE-backed platforms — actively seek agencies with meaningful managed care, commercial insurance, or private pay revenue because it signals less government dependency and often higher per-episode margins. Every 10–15 percentage points of managed care or private pay revenue above the market average can meaningfully lift your multiple.
Yes. Home health agency acquisitions are SBA 7(a) eligible, making them accessible to individual buyers with healthcare backgrounds who may not have access to institutional capital. A typical SBA-financed home health acquisition involves a 10% buyer equity injection, an SBA 7(a) loan covering 75–80% of the purchase price, and a seller note of 10–15% that is often subordinated to the SBA lender. Lenders underwriting these deals will closely scrutinize the agency's Medicare certification status, billing compliance history, payor mix, and CHOW timeline — all of which affect loan approval and deal structuring.
Home health agency due diligence goes well beyond standard financial review. Buyers will conduct a detailed billing compliance audit covering three years of Medicare and Medicaid claims, including claim denial rates, overpayment history, and any RAC or OIG audit activity. They will verify the status of all state licenses, Medicare/Medicaid certifications, and accreditations, and assess CMS star ratings and OASIS documentation quality. Staff credentialing, employment agreements, and turnover rates are reviewed alongside payor mix analysis and referral source concentration. Technology infrastructure — including EVV compliance and EHR systems — is increasingly a formal due diligence item as buyers assess integration costs.
Most home health agency sales take 12–24 months from the decision to sell to closing, accounting for preparation time, marketing, buyer diligence, and the CHOW process. Sellers who begin preparation early — obtaining a clean compliance audit, organizing three years of financials, documenting referral relationships, and ensuring all licenses are current — can compress the timeline and reduce the risk of deal re-trades during diligence. The CHOW approval period with CMS, which typically runs 90–180 days post-close, is a fixed variable that sellers cannot accelerate but can plan around by selecting deal structures with appropriate holdbacks and earnout provisions.
The single highest-impact action most owners can take is reducing owner dependency by building a capable clinical and administrative management team before going to market. Buyers pay for transferable businesses — agencies where the director of nursing, billing manager, and referral relationships can survive the ownership transition command meaningfully higher multiples and attract more competitive offers. Paired with a clean third-party billing compliance audit and documented institutional referral relationships, a well-staffed agency with operational infrastructure in place is positioned to achieve the upper range of the 3.5x–6x EBITDA multiple spectrum.
More Home Health Agency Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers